Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer [0.03%]
血管紧张素II受体拮抗剂在泌尿生殖系统肿瘤中的抗血管生成作用研究
Akira Miyajima,Eiji Kikuchi,Takeo Kosaka et al.
Akira Miyajima et al.
The potential for angiotensin II (AII) to promote tumor growth has been suspected based on its known hormonal actions and its vasoconstrictor effect. It has been suggested that angiotensin-converting enzyme (ACE) inhibitors may offer protec...
Recent progress: gynecologic oncology group trials in uterine corpus tumors [0.03%]
子宫体肿瘤妇科肿瘤研究进展：妇科肿瘤协作组的临床试验
Louise P King,David Scott Miller
Louise P King
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to neoplasms of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic s...